KAPA
Kairos Pharma, Ltd.
NYSE MKT: KAPA · HEALTHCARE · BIOTECHNOLOGY
$0.55
-6.44% today
Updated 2026-04-29
Market cap
$12.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
0.6M
Kairos Pharma, Ltd. (KAPA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 7
Last 7 quarters
Avg EPS surprise
-27.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-40.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+6.5%
2025-12-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.07 | -333.3% | $0.70 | $0.73 | +4.2% |
| 2025-12-03 | $-0.07 | +6.7% | $0.85 | $0.91 | +6.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.03 | $-0.07 | -333.3% | — | — |
| 2025-09-30 | $-0.08 | $-0.07 | +6.7% | — | — |
| 2025-06-30 | $-0.05 | $-0.07 | -30.0% | — | — |
| 2025-03-31 | $-0.05 | $-0.08 | -60.0% | — | — |
| 2024-12-31 | $-0.02 | $-0.05 | -150.0% | — | — |
| 2024-09-30 | $-0.02 | $-0.05 | -150.0% | — | — |
| 2024-06-30 | $0.00 | $-0.02 | — | — | — |
Frequently asked questions
Has Kairos Pharma, Ltd. beaten earnings estimates?
Kairos Pharma, Ltd. has beaten Wall Street EPS estimates in 1 of its last 7 quarterly reports, with an average EPS surprise of -27.8% over the last 3 quarters.
How does KAPA stock react to earnings?
KAPA stock has moved an average of +5.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.